Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

FTSE 100 on track for fourth session of gains

Published 24/10/2019, 09:36
Updated 24/10/2019, 09:36
FTSE 100 on track for fourth session of gains

FTSE 100 on track for fourth session of gains

By Muvija M and Shashwat Awasthi

(Reuters) - London's FTSE 100 rose on Thursday along with its European counterparts, helped by strong French manufacturing data and gains in AstraZeneca after a 2019 forecast upgrade.

The blue-chip index (FTSE) climbed 0.7% to a near one-month high by 0730 GMT, on course for its fourth session of gains. A dip in sterling limited the FTSE 250 (FTMC) to a 0.2% gain.

After rising to session highs following data from France, the main bourse eased slightly after another survey showed employment in Germany's private sector fell for the first time in six years in October.

The conflicting data come at a time of existing fears over global economic growth, as multiple unfavourable events including the U.S.-China trade tussle and Brexit play out.

In the past two weeks UK shares have been volatile with major Brexit developments including Prime Minister Boris Johnson striking a new Brexit deal with the European bloc and lawmakers at home forcing his hand into asking for another extension to the divorce.

'U.S.-CHINA AND BREXIT IN LIMBO'

The FTSE 100, whose components rake in more than two-thirds of their earnings in U.S. dollars, is on course for its best weekly gain since early June, as uncertainties over the course of UK's EU departure have dented the value of sterling.

AstraZeneca (L:AZN) gained 3%, its biggest one-day rise in three months, after the pharmaceutical giant raised its annual product sales forecast for the second time this year.

Analytics and decision tools provider Relx (L:REL) and industrial software company Aveva (L:AVV) added 2.5% each following trading updates.

"There's not been a huge catalyst for markets this week. Earnings are largely topping beaten-down estimates. U.S.-China and Brexit are in limbo," Markets.com analyst Neil Wilson said.

On the other end of the spectrum was Royal Bank of Scotland (L:RBS) that skidded 3% as it swung to a third-quarter loss due to a fresh 900 million pound provision to settle mis-selling claims.

A notable mid-cap performer was Kaz Minerals (L:KAZ) that jumped 7% after record third-quarter copper production as it ramped up operations at its biggest mines in Kazakhstan.

Woodford Patient Capital Trust (L:WPCT), formerly run by high-profile money manager Neil Woodford, jumped 22% as the company appointed asset manager Schroders (L:SDR) as its new portfolio manager.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.